Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks

Circulation

Volumn 100, Issue 10, 1999, Pages 1125-1130

  Katz, Amos ^a   Sweeney, Robert J ^c   Gill, Robert M ^c   Reid, Philip R ^c   Prystowsky, Eric N ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Indiana Heart Institute   (United States)

^c NONE

Author keywords

Atrium; Defibrillation; Electrophysiology; Fibrillation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DEFIBRILLATOR; DOG; ENDOCARDIUM; EPICARDIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033533526     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.10.1125     Document Type: Article

References (21)

1. Lemberg L, Castellanos A, Swenson J, Gosselin A. Arrhythmias related to cardioversion. Circulation. 1964;30:163-170.
2. DeSilva RA, Grayboys TB, Podrid PJ, Lown B. Cardioversion and defibrillation. Am Heart J. 1980;100:881-895.
3. Waldecker B, Brugada P, Zehender M, Stevenson W, Wellens HJ. Dysrhythmias after direct-current cardioversion. Am J Cardiol. 1986;57: 120-123.
4. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T. Long term outcome with automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989;13:1353-1361.
5. Mirowski M. The automatic implantable cardioverter defibrillator: an overview. J Am Coll Cardiol. 1985;6:461-466.
6. Kelly PA, Cannon DS, Garan H III. The automatic implantable cardioverter defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol. 1988;11: 1278-1286.
7. Katz A, Evans J, Fogel RI, Schier J, Matheny RG, Baranowski GM, Prystowsky EN. Atrial fibrillation/flutter induced by implantable ventricular defibrillator shocks: difference between epicardial and endocardial energy delivery. J Cardiovasc Electrophysiol. 1997;8:35-41.
8. Ciccone JM, Saksena S, Shah Y, Pantopoulos D. A prospective randomized study of clinical efficacy and safety of transvenous cardioversion for ventricular tachycardia termination. Circulation. 1985;71: 571-578.
9. Jones GK, Johnson G, Troutman Buono G, Gartman DM, Kudenchuk PJ, Poole JE, Dolack GL, Bardy GH. Incidence of atrial fibrillation following ventricular defibrillation with transvenous lead system in man. J Cardiovasc Electrophysiol. 1992;3:411-417.
10. Florin TJ, Weiss DN, Peters RW, Shorofsky SR, Gold MR. Induction of atrial fibrillation with low-energy defibrillator shock in patients with implantable cardioverter defibrillators. Am J Cardiol. 1997;80:960-962.
11. Gill RM, Sweeney RJ, Reid PR. The defibrillation threshold: a comparison of anesthetics and measurement methods. Pacing Clin Electrophysiol. 1993;16:708-714.
12. Peleska B. Cardiac arrhythmias following condenser discharge and their dependence upon strength of current and pulse of cardiac cycle. Circ Res. 1963;13:21-32.
13. Orias A, Gilbert JC, Siebens AA, Brooks C. Effectiveness of single rectangular electrical pulse of known duration and strength in evoking auricular fibrillation. Am J Physiol. 1950;163:219-225.
14. Frazier DW, Wolf PD, Wharton JM, Tang AS, Smith WM, Ideker PE. Stimulus-induced critical point. J Clin Invest. 1989;83:1039-1052.
15. Chen PS, Shibata N, Dixon EG, Martin RO, Ideker RE. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation. 1986;73:1022-1028.
16. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
17. Wellens HJ, Lau CP, Luderitz B, Aktar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordans L, Ayers G. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation. 1998;98:1651-1656.
18. Daubert JP, Fraizer DW, Wolf PD, Franz MR, Smith WM, Ideker RE. Response of relative refractory canine myocardium to monophasic and biphasic shocks. Circulation. 1991;84:2522-2538.
19. Sweeney RJ, Gill RM, Reid PR. Increased action potential prolongation by low-voltage biphasic versus monophasic field stimulation. J Am Coll Cardiol 1995;86A. Abstract.
20. Sweeney RJ, Gill RM, Reid PR. Refractory period extension for monophasic versus biphasic shocks. J Am Coll Cardiol. 1994;12:835. Abstract.
21. Kelly PA, Mann DE, Reiter MJ, Harken AH. Atrial fibrillation after cardioverter defibrillator implantation. Pacing Clin Electrophysiol. 1995; 18:379-385.